Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€357.30
13.12.23
€396.00
04.07.24
10.15%
24.01.24

RudolfL 
13.12.23 50%
sell
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€496.50
09.12.23
-
09.12.24
2.24%
23.12.23

KongVestor 
09.12.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€31.93
08.12.23
-
08.12.24
0.11%
08.12.23

Could be very worthwhile Investment >20% year
bundfuture 
08.12.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€32.00
07.12.23
€38.00
07.12.24
-15.23%
26.03.24

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
07.12.23 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€31.89
05.12.23
-
05.12.24
0.49%
09.12.23

nero 
05.12.23 0%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€168.10
04.12.23
€184.00
21.06.24
-15.98%
12.04.24

RudolfL 
04.12.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€26.65
04.12.23
-
04.01.24
-0.19%
05.01.24

fabudagga 
04.12.23 50%
sell
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€28.11
27.11.23
-
27.11.24
1.03%
09.12.23

Akuma 
27.11.23 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€31.53
27.11.23
-
27.11.24
1.63%
09.12.23

Akuma 
27.11.23 0%
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€87.32
27.11.23
€109.00
08.06.24
9.54%
17.04.24

RudolfL 
27.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€32.85
26.11.23
€45.00
26.12.23
0.47%
27.12.23

Sybiris21 
26.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€32.85
26.11.23
-
26.12.23
0.47%
27.12.23

Ines 
26.11.23 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€32.77
24.11.23
€35.00
21.12.23
-6.78%
29.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
24.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€34.07
21.11.23
-
21.12.23
-4.09%
22.12.23

Alowa 
21.11.23 50%
buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€8.45
21.11.23
-
21.12.23
-1.78%
22.12.23

Alowa 
21.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€33.84
21.11.23
€35.00
21.12.23
-3.16%
24.11.23

Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Traumtanz 
21.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€34.23
20.11.23
€42.00
20.11.24
-6.50%
07.12.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
20.11.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€35.71
20.11.23
-
20.11.24
-8.25%
24.11.23

Bankster 
20.11.23 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€68.52
18.11.23
-
18.11.24
7.47%
03.12.23

fenjal 
18.11.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.50
15.11.23
€165.00
15.12.23
4.25%
16.12.23

kschabe 
15.11.23 50%
sell
Bayer AG

Start price
Target price
Perf. (%)
€40.83
15.11.23
€35.00
15.11.24
-19.02%
22.11.23

Probably not worthwhile Investment
Higher risks for its business
kschabe 
15.11.23 60%
buy
Exact Sciences

Start price
Target price
Perf. (%)
€55.41
11.11.23
€105.00
11.12.23
7.56%
25.11.23

Revenue growth >5% per year expected
Rising EBIT margin expected
Standard Investments for future growth
negative Cash Flow expected
miromb 
11.11.23 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€8.06
11.11.23
-
11.11.24
2.23%
19.11.23

Taurito 
11.11.23 0%
sell
Illumina Inc.

Start price
Target price
Perf. (%)
€92.51
11.11.23
€46.00
11.11.24
-2.85%
25.11.23

nvestor 
11.11.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.86
04.11.23
€89.00
04.12.23
-4.82%
05.12.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
04.11.23 50%